Fermenta Biotech Ltd — Important, 11-11-2025: Company Update

Fermenta Biotech reported robust financial results for the half-year and quarter. Consolidated H1FY26 revenue rose 57% YoY to INR 280.7 Cr, with EBITDA soaring 173% to INR 69.1 Cr, and net profit jumping 664% to INR 39.6 Cr. Key operational drivers included a 74% volume growth in human nutrition and a 35% increase in animal nutrition realization. The company secured a patent for its plant-based Vitamin D3, poised to capture new market segments. Additionally, its Environment Division was strategically transferred to a wholly-owned subsidiary for INR 19 Cr to drive focused expansion.